https://doi.org/10.1016/s1473-3099(21)00485-0
R
Raphaël Clère-Jehl
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
86
Papers
9.5K
Citations
27
h-index
48
i10-index
Raphaël Clère-Jehl is an academic researcher from Hôpital d'Hautepierre. The author has contributed to research in topics: COVID-19 Clinical Research Studies & Long-Term Effects of COVID-19 & Sepsis Diagnosis and Treatment. The author has an h-index of 27, co-authored 74 publications.
ORCID: 0000-0002-8550-4245Papers by this author
worksRemdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
2021 · The Lancet Infectious Diseases · 338 citations
Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3)
2023 · The Lancet Respiratory Medicine · 219 citations
https://doi.org/10.1016/s2213-2600(23)00092-9
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022 · JAMA · 149 citations
https://doi.org/10.1001/jama.2022.2910
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022 · JAMA · 134 citations
https://doi.org/10.1001/jama.2022.23257
Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study
2021 · Annals of Intensive Care · 57 citations
https://doi.org/10.1186/s13613-021-00809-5
Intravenous Vitamin C for Patients Hospitalized With COVID-19
2023 · JAMA · 45 citations
https://doi.org/10.1001/jama.2023.21407
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat